跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FRAGMIN dalteparin sodium 10,000 Anti-XaIU/1mL injection syringe (graduated) - TGA Drug Approval Details
Approvals
/
TGA
/
FRAGMIN dalteparin sodium 10,000 Anti-XaIU/1mL injection syringe (graduated)
Approved
STANDARD
FRAGMIN dalteparin sodium 10,000 Anti-XaIU/1mL injection syringe (graduated)
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
03e3308cdd0f0dce
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
03e3308cdd0f0dce
Product Name
FRAGMIN dalteparin sodium 10,000 Anti-XaIU/1mL injection syringe (graduated)
Artg Id
66626
Artg Name
FRAGMIN dalteparin sodium 10,000 anti-Xa IU/1mL injection syringe (graduated)
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1998-11-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8b4b190d516d987b810c0e4763bedb33.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6ce347540e7250f93d4b652425487615.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
03e3308cdd0f0dce
Type
Standard
Back to TGA Approvals